Heart Imaging Study for People With Chronic Heart Failure
Studies a PET heart scan that tracks nerve activity in adults with heart failure.
Plain-language title generated from the registry record
Registry title: 18F-MFBG Cardiac Imaging for Heart Failure Administration
Key facts
- Where
- Chengdu, ChinaSee the site
Could this be for you?
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 18 and 80 years old?
Source: NCT06149195, who can take part
Where in China
- Zhi Ling DingChengdu, ChinaNo longer taking part
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- Sichuan Provincial People's Hospital
- Trial code
- NCT06149195
- Record updated
- 24 January 2024
- Original description
The clinical feasibility of 18F-FMBG cardiac PET imaging will be observed in sympathetic nervous system activity in patients with heart failure, predicted cardiac events, guided ICD implantation, and evaluated therapy efficiency.Read full original descriptionShow less
18F-meta-fluorobenzylguanidine Cardiac Imaging for Evaluation of Chronic Heart Failure
The clinical feasibility of 18F-FMBG cardiac PET imaging will be observed in sympathetic nervous system activity in patients with heart failure, predicted cardiac events, guided ICD implantation, and evaluated therapy efficiency.
Inclusion: 1. Clinically confirmed patient with chronic heart failure, LVEF ≤ 40%, cardiac function NYHA 2-3 grade, survival period greater than 1 year, evaluated by the Heart Failure Center of Sichuan Provincial People's Hospital; 2. Chronic heart failure patients were evaluated by the Cardiology Department of Sichuan Provincial People's Hospital 5-10 days before ICD implantation; 3. All patients above have signed an informed consent form.
Exclusion: 7. The patient has contraindications for ICD implantation surgery; 1. Heart failure, heart function NYHA levels ⅠOR Ⅳ; 3. Heart transplant patients; 4. Patients with malignant tumors; 5. Heart valve disease; 6. Myocardial infarction occurred within the past three months; 2. The patient has already implanted ICD or CRT; 8. The patient does not cooperate or is unwilling to conduct the study.